Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Orphan Drug Designation Granted to SerpinPC for the Treatment of Hemophilia B

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Announces Orphan Drug Designation Granted to SerpinPC for the Treatment of Hemophilia B

Related Keywords

London ,City Of ,United Kingdom ,Boston ,Massachusetts ,United States ,Russia ,Ukraine ,Saurabh Saha ,Kristenk Sheppard ,Exchange Commission ,Drug Administration ,Research Development ,Centessa Pharmaceuticals ,Nasdaq ,Open Label Extension ,Orphan Drug Designation ,Annualized Bleeding Rate ,Chief Executive Officer ,Drug Designation ,Annual Report ,Quarterly Reports ,Investegate Announcements ,Investegate Company Announcements ,Centessa Pharmaceuticals Plc ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,